Scinai Immunotherapeutics : The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance - Form 6-K marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Item 8.01 Other Information As previously reported, on November 30, 2023, a Nasdaq Hearings Panel provided Vivos Therapeutics, Inc. until March 19, 2024 to regain compliance.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 2, 2024, Mesa Air Group, Inc. was notified by the.
Priveterra Acquisition Corp. II today announced that on April 29, 2024, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC.
Quantum Provides Updated Plan to Nasdaq tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.